FAKTOR-OPTIONSSCHEIN - QUEST DIAGNOSTICS | Real-time Bid/Ask 08:58:36 2024-06-24 EDT | ||
| 8.41 EUR / 8.57 EUR | -1.51% |
|
| Current month | +4.23% | ||
| 1 month | +16.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-06-24 | 8.41 | -2.44% |
| 24-06-21 | 8.62 | -2.71% |
| 24-06-20 | 8.86 | -2.64% |
| 24-06-19 | 9.1 | -0.44% |
| 24-06-18 | 9.14 | -0.33% |
Delayed Quote Börse Stuttgart
Last update June 24, 2024 at 06:29 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | MG34Y8 |
| ISIN | DE000MG34Y83 |
| Date issued | 2024-04-26 |
| Strike | 166.8 $ |
| Maturity | Unlimited |
| Parity | 3.04 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.76 € |
|---|---|
| Lowest since issue | 6.9 € |
| Spread | 0.15 € |
| Spread % | 1.75% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
139
USD
Average target price
147
USD
Spread / Average Target
+5.79%
- Stock Market
- Certificates
- Certificat
